Onkologie, Hämatologie - Daten und Informationen
SitemapSitemap  


8 Prophylaxe und Therapie von Infektionen: Literatur

Autor/en: H. Link
Letzte Änderung: 25.01.2006
  • Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP.
    Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
    Am J Med 1996;101:170-176. PM:8757357
    [Medline]


  • Bertz H, Auner HW, Weissinger F, Salwender HJ, Einsele H, Egerer G, Sandherr M, Schuttrumpf S, Sudhoff T, Maschmeyer G.
    Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hemat 2003;82:167-174. PM:13680166
    [Medline]


  • Bohme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, Heussel G, Heussel CP, Junghanss C, Kern WK, Kubin T, Maschmeyer G, Sezer O, Silling G, Sudhoff T, Szelenyi DH, Ullmann AJ.
    Treatment of fungal infections in hematology and oncology - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hematol 2003;82:133-140. PM:13680170
    [Medline]


  • Boogaerts M, Maertens J, van Hoof A, De Bock R, Fillet G, Peetermans M, Selleslag D, Vandercam B, Vandewoude K, Zachee P, De Beule K.
    Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
    J Antimicrob Chemother 2001a;48:97-103. PM:11418517
    [Medline]


  • Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K.
    Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Ann Intern Med 2001b;135:412-422. PM:11560454
    [Medline]


  • Buchheidt D, Bohme A, Cornely OA, Fatkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern WV, Schiel X, Sezer O, Sudhoff T, Szelenyi H.
    Diagnosis and treatment of documented infections in neutropenic patients - recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hemat 2003;82:127-132. PM:13680171
    [Medline]


  • Cornely OA, Bohme A, Buchheidt D, Glasmacher A, Kahl C, Karthaus M, Kern W, Kruger W, Maschmeyer G, Ritter J, Salwender HJ, Sandherr M, Schiel X, Schuttrumpf S, Sieniawski M, Silling G, Ullmann AJ, Wolf HH.
    Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hematol 2003;82:186-200. PM:13680164
    [Medline]


  • de Pauw BE, Deresinski SC, Feld R, Lane Allman EF, Donnelly JP.
    Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    Ann Intern Med 1994;120:834-844. PM:8154643
    [Medline]


  • Donnelly JP, Maschmeyer G, Daenen S.
    Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia - ciprofloxacin versus co-trimoxazole plus colistin.
    Eur J Cancer 1992;28:873-878. PM:1524913
    [Medline]


  • Ehninger G, Schuler U, Brammer S, Aulitzky W, Binder C, Boehme E, Egerer G, Ganser A, Peschel C, Schwerdfeger R, Silling G, Zander A, Wandt H.
    Intravenous followed by oral itraconazole versus intravenous amphotericin B as empirical antifungal therapy for febrile neutropenic haematological cancer patients.
    Blood 2002;Abstract#3631.


  • Einsele H, Bertz H, Beyer J, Kiehl MG, Runde V, Kolb HJ, Holler E, Beck R, Schwerdfeger R, Schumacher U, Hebart H, Martin H, Kienast J, Ullmann AJ, Maschmeyer G, Kruger W, Niederwieser D, Link H, Schmidt CA, Oettle H, Klingebiel T.
    Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hematol 2003;82:175-185. PM:13680165
    [Medline]


  • Elting LS, Bodey GP, Keefe BH.
    Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
    Clin Infect Dis 1992;14:1201-1207. PM:1623076
    [Medline]


  • EORTC, International Antimicrobial Therapy Cooperative Group.
    Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
    N Engl J Med 1987;317:1692-1698. PM:2892130
    [Medline]


  • Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H.
    Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
    Clin Infect Dis 2001;32:1718-1725. PM:11360214
    [Medline]


  • Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey T, Clift R, Petersdorf E, Radich J, Sanders J, Storb R, Sullivan K, Anasetti C.
    Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
    N Engl J Med 1998;338:962-968. PM:9521984
    [Medline]


  • Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B.
    Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    N Engl J Med 2002;347:408-415. PM:12167683
    [Medline]


  • Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS.
    2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
    Clin Infect Dis 2002;34:730-751. PM:11850858
    http://www.journals.uchicago.edu/CID/journal/issues/v34n6/011605/011605.html
    [Medline]


  • Hughes WT, Smith BL.
    Intermittent chemoprophylaxis for pneumocystis carinii pneumonia.
    Antimicrob Agents Chemother 1983;24:300-301. PM:6605717
    [Medline]


  • Kanda Y, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Arai C, Matsuyama T, Takezako N, Miwa A, Kern W, Kami M, Akiyama H, Hirai H, Togawa A.
    Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Cancer 2000;89:1611-1625. PM:11013378
    [Medline]


  • Kern WV, Beyer J, Böhme A, Buchheidt D, Cornely O, Einsele H, Kisro J, Kruger W, Maschmeyer G, Ruhnke M, Schmidt CA, Schwartz S, Szelenyi H.
    Infektionsprophylaxe bei neutropenischen Patienten - Leitlinien der Arbeitsgemeinschaft Infektionen in der Hämatologie und Onkologie.
    Dtsch Med Wochenschr 2000;125:1582-1588. PM:11199452
    [Medline]


  • Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J.
    The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
    Journal of Clinical Oncology 2000;18:3038-3051. PM:0010944139
    [Medline]


  • Link H, Bohme A, Cornely OA, Hoffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW.
    Antimicrobial therapy of unexplained fever in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
    Ann Hematol 2003;82:105-117. PM:13680173
    [Medline]


  • Link H, Hess CF, Albers P, Schmoll H-J, Reimers HJ, von Minckwitz G, Nowrousian MR, Welte K.
    Rationale Therapie mit den hämatopoetischen Wachstumsfaktoren G-CSF und GM-CSF.
    Onkologe 2001;7:1329-1341.
    http://www.link.springer.de/link/service/journals/00761/bibs/1007012/10071329.htm


  • Link H, Hiddemann W, Maschmeyer G, Buchheidt D, Glass B, Cornely OA, Wilhelm M, Helmerking M, Adam D, and the PEG-Study group.
    Antimicrobial therapy in neutropenic patients with unexplained fever, PEG-Study II.
    Onkologie 1997;20:132.


  • Link H, Maschmeyer G, Meyer P, Hiddemann W, Stille W, Helmerking M, Adam D, for the study group of the Paul Ehrlich Society for Chemotherapy.
    Interventional antimicrobial therapy in febrile neutropenic patients.
    Ann Hemat 1994;69:231-243. PM:7948312
    [Medline]


  • Link H, Vöhringer HF, Wingen F, Brägas B, Schwardt A, Ehninger G.
    Pentamidine aerosol for prophylaxis of pneumocystis carinii pneumonia after bone marrow transplantation.
    Bone Marrow Transplant 1993;11:403-406. PM:8504275
    [Medline]


  • Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J.
    Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ann Hematol 2003;82:118-126. PM:13680172
    [Medline]


  • Maschmeyer G, Böhme A, Buchheidt D, Cornely O, Fricke HJ, Karthaus M, Lehrnbecher T, Link H, Wilhelm M.
    Diagnostik und Therapie von Infektionen bei Patienten in der Hämatologie und Onkologie.
    Chemotherapie Journal 2004


  • Maschmeyer G, Link H, Hiddemann W, Meyer P, Helmerking M, Eisenmann E, Schmitt J, Adam D.
    Pulmonary infiltrations in febrile neutropenic patients. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study.
    Cancer 1994;73:2296-2304. PM:8168033
    [Medline]


  • Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J, the Caspofungin Invasive Candidiasis Study Group.
    Comparison of caspofungin and amphotericin B for invasive candidiasis.
    N Engl J Med 2002;347:2020-2029. PM:12490683
    http://content.nejm.org/cgi/content/abstract/347/25/2020
    [Medline]


  • Murray BE.
    Vancomycin-resistant enterococcal infections.
    N Engl J Med 2000;342:710-721. PM:10706902
    [Medline]


  • Opal SM, Asp AA, Cannady PB Jr, Morse PL, Burton LJ, Hammer PG.
    Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction.
    J Infect Dis 1986;153:634-637. PM:2936830
    [Medline]


  • Pizzo PA.
    Review articles: Fever in immunocompromised patients.
    N Engl J Med 1999;341:893-900. PM:0010486422
    [Medline]


  • Pizzo PA, Ladisch S, Robichaud K.
    Treatment of gram-positive septicemia in cancer patients.
    Cancer 1980;45:206-207. PM:7351004
    [Medline]


  • Sleijfer DT, Mulder NH, de Vries-Hospers HG, Fidler V, Nieweg HO, Van der Waaij D, Van Saene HKF.
    Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.
    Eur J Cancer 1980;16:859-869. PM:6997054
    [Medline]


  • Tuan IZ, Dennison D, Weisdorf DJ.
    Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992;10:267-272. PM:14tgh22481
    [Medline]


  • Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH.
    Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
    Biol Blood Marrow Transplant 2000;6:35-43. PM:10707997
    [Medline]


  • Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdiere M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    N Engl J Med 2002;346:225-234. PM:11807146
    [Medline]


  • Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.
    Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    N Engl J Med 2004;351:1391-1402. PM:15459300
    http://content.nejm.org/cgi/content/abstract/351/14/1391
    [Medline]


  • Weems JJ Jr, Davis BJ, Tablan OC, Kaufman L, Martone WJ.
    Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy.
    Infect Control 1987;8:71-75. PM:3470268
    [Medline]


  • Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G.
    Filgrastim (r-metHuG-CSF): The first 10 years.
    Blood 1996;88:1907-1929. PM:8822908
    [Medline]


  • Wingard JR, White MH, Anaissie E, Raffalli J, Goodman J, Arrieta A.
    A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
    Clin Infect Dis 2000;31:1155-1163. PM:11073745
    [Medline]


  • Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ et al.
    Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial [see comments].
    Ann Inter Med 1993;118:495-503. PM:8442620
    [Medline]


Sponsor
Die Publikation dieses Artikels wird gefördert durch:
mehr  Wyeth
Bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag"
Deutscher Ärzte-Verlag  Deutscher Ärzte-Verlag
[Mehr]